{
    "NCT05508789": {
        "inclusion": {
            "0": [
                "The criterion requires a gradual and progressive change in memory function for \u22656 months. The patient note mentions 'progressive memory loss' but does not specify the duration. It's possible that a good patient note could miss such information if not explicitly stated.",
                [
                    1
                ],
                "not enough information"
            ],
            "1": [
                "The criterion requires a MMSE score of 20 to 28 inclusive. The patient note states 'MMSE score of 21'.",
                [
                    6
                ],
                "included"
            ],
            "2": [
                "The criterion requires meeting flortaucipir F18 scan criteria. There is no mention of flortaucipir F18 scan in the patient note.",
                [],
                "not included"
            ],
            "3": [
                "The criterion requires meeting florbetapir F18 scan criteria. There is no mention of florbetapir F18 scan in the patient note.",
                [],
                "not included"
            ],
            "4": [
                "The criterion requires a study partner who is in frequent contact with the participant and available for assessments. The patient note mentions that the patient 'will provide informed consent, and will comply with the trial protocol without any practical issues' but does not mention a study partner.",
                [],
                "not enough information"
            ]
        },
        "exclusion": {
            "0": [
                "The patient has early Alzheimer's disease, but there is no mention of other significant neurological diseases affecting the central nervous system. The note does not provide direct evidence of other neurological conditions, but the diagnosis of Alzheimer's disease suggests a focus on this condition. It is unlikely that a good patient note would miss significant other neurological conditions if they existed.",
                [
                    1,
                    2,
                    3,
                    4,
                    5,
                    6,
                    7
                ],
                "not excluded"
            ],
            "1": [
                "The patient does not have any mention of current serious or unstable illnesses including cardiovascular, hepatic, renal, gastroenterologic, respiratory, endocrinologic, psychiatric, immunologic, or hematologic diseases. There is no direct evidence provided, but it is unlikely that a good patient note would miss such significant conditions if they existed.",
                [],
                "not excluded"
            ],
            "2": [
                "The patient does not mention a history of cancer within the last 5 years, except for low-risk cancers. There is no direct evidence provided, but it is unlikely that a good patient note would miss such significant information if it existed.",
                [],
                "not excluded"
            ],
            "3": [
                "The patient does not mention any contraindication to MRI or PET scans.",
                [],
                "not excluded"
            ]
        }
    },
    "NCT06297590": {
        "inclusion": {
            "0": [
                "The patient's BMI is not mentioned in the note, so it's not applicable to judge whether the criterion is met or not.",
                [],
                "not applicable"
            ],
            "1": [
                "The patient has gradual and progressive memory loss, which fits the description of gradual and progressive change in memory function for \u22656 months.",
                [
                    1,
                    2
                ],
                "included"
            ],
            "2": [
                "The patient's MMSE score is 21, which falls within the range of 18 to 30.",
                [
                    6
                ],
                "included"
            ],
            "3": [
                "The patient's clinical dementia rating (CDR) global score and memory box score are not mentioned in the note. It's not enough information to determine if they meet the criteria.",
                [],
                "not enough information"
            ],
            "4": [
                "The patient's flortaucipir F18 PET scan results are not mentioned in the note. It's not enough information to determine if they demonstrate evidence of tau pathology.",
                [],
                "not enough information"
            ],
            "5": [
                "There is no information regarding contraceptive requirements for males or childbearing potential for females.",
                [],
                "not enough information"
            ],
            "6": [
                "There is no information regarding the presence of up to 2 study partners who are with the participant at least 10 hours per week and one of whom can attend study appointments.",
                [],
                "not enough information"
            ]
        },
        "exclusion": {
            "0": [
                "The patient does not have any mentioned serious or unstable illnesses other than Alzheimer's Disease, and there is no mention of life expectancy being less than 24 months. It is not applicable to infer other conditions without evidence.",
                [],
                "not applicable"
            ],
            "1": [
                "No mention of sensitivity to flortaucipir F18 in the patient note.",
                [],
                "not applicable"
            ],
            "2": [
                "No mention of contraindication to MRI, including metal implants or claustrophobia.",
                [],
                "not applicable"
            ],
            "3": [
                "No mention of current exposure to amyloid-targeted therapy (ATT).",
                [],
                "not excluded"
            ],
            "4": [
                "No mention of previous exposure to any investigational medicinal product administered intrathecal (IT) or any anti-tau therapy.",
                [],
                "not excluded"
            ],
            "5": [
                "No mention of a history of clinically significant back pain, back pathology, or back injury.",
                [],
                "not excluded"
            ]
        }
    },
    "NCT05026866": {
        "inclusion": {
            "0": [
                "The patient note does not mention a TICS-M score. It is not possible to infer the cognitive status from the provided information. Therefore, the criterion is not applicable.",
                [],
                "not applicable"
            ],
            "1": [
                "The patient note does not mention a phosphorylated tau (P-tau) result. It is not possible to infer the presence of amyloid and early-tau pathology from the provided information.",
                [],
                "not enough information"
            ],
            "2": [
                "The patient note does not mention a reliable study partner or backup study partner. It is not possible to infer the availability of such partners from the provided information.",
                [],
                "not enough information"
            ],
            "3": [
                "The patient note does not mention literacy, vision, or hearing. It is not possible to infer these conditions from the provided information.",
                [],
                "not enough information"
            ],
            "4": [
                "The patient note does not mention contraceptive use by men or women. It is not possible to infer this information from the provided information.",
                [],
                "not enough information"
            ],
            "5": [
                "The patient note does not mention female participants' reproductive status. It is not possible to infer the eligibility of female participants from the provided information.",
                [],
                "not enough information"
            ]
        },
        "exclusion": {
            "0": [
                "The patient has progressive memory loss and jerking movements, indicating cognitive deficits and memory dysfunction, which are symptoms of Alzheimer's Disease. Therefore, the criterion is applicable and the patient is not excluded.",
                [
                    1,
                    2,
                    3,
                    4,
                    5,
                    6
                ],
                "not excluded"
            ],
            "1": [
                "The patient has no mention of current serious or unstable illnesses that could interfere with the study or have a life expectancy of \u22645 years.",
                [],
                "not excluded"
            ],
            "2": [
                "The patient has no history of cancer with high risk of recurrence.",
                [],
                "not excluded"
            ],
            "3": [
                "The patient has no history of clinically significant multiple or severe drug allergies, or severe posttreatment hypersensitivity reactions.",
                [],
                "not excluded"
            ],
            "4": [
                "The patient has no clinically important abnormalities at screening on MRI or clinical laboratory test results.",
                [],
                "not excluded"
            ],
            "5": [
                "The patient has no contraindications for MRI, including claustrophobia or the presence of contraindicated metal implants/cardiac pacemaker.",
                [],
                "not excluded"
            ],
            "6": [
                "The patient has no centrally read MRI demonstrating presence of amyloid-related imaging abnormalities (ARIA-E), >4 cerebral microhemorrhages, more than 1 area of superficial siderosis, any macrohemorrhage or severe white matter disease at screening.",
                [],
                "not excluded"
            ],
            "7": [
                "The patient has not had prior treatment with a passive anti-amyloid immunotherapy within 5 half-lives prior to randomization.",
                [],
                "not excluded"
            ],
            "8": [
                "The patient has not received active immunization against amyloid beta (A\u03b2) in any other study.",
                [],
                "not excluded"
            ],
            "9": [
                "The patient has not received active immunization against A\u03b2 in any other study.",
                [],
                "not excluded"
            ],
            "10": [
                "The patient has no current or previous use of prescription medications used as treatment for mild cognitive impairment (MCI) or AD.",
                [],
                "not excluded"
            ],
            "11": [
                "Same as the main study except contraindications for florbetapir F 18 PET are exclusionary. The patient note does not mention any contraindications for florbetapir F 18 PET.",
                [],
                "not excluded"
            ]
        }
    },
    "NCT06653153": {
        "inclusion": {
            "0": [
                "The criterion requires a phosphorylated tau (P-tau) result consistent with the presence of amyloid pathology. The patient note does not mention any P-tau results.",
                [],
                "not enough information"
            ],
            "1": [
                "The criterion requires a reliable study partner and backup study partner familiar with overall function and behavior. The patient note does not mention any study partners.",
                [],
                "not enough information"
            ],
            "2": [
                "The criterion requires adequate literacy, vision, and hearing for neuropsychological testing at screening. The patient note does not mention any specific details about literacy, vision, or hearing.",
                [],
                "not enough information"
            ],
            "3": [
                "The criterion requires an MMSE score consistent with no to minimal cognitive impairment. The patient has an MMSE score of 21. An MMSE score of 21 is consistent with moderate cognitive impairment, not no to minimal impairment.",
                [
                    6
                ],
                "not included"
            ],
            "4": [
                "The criterion requires a FAQ score consistent with no to minimal functional impairment. The patient note does not mention any FAQ scores.",
                [],
                "not enough information"
            ],
            "5": [
                "The criterion requires that if currently receiving medications as symptomatic treatment for AD, the dose has been stable for at least 30 days before screening. The patient note does not mention any medications for AD.",
                [],
                "not enough information"
            ]
        },
        "exclusion": {
            "0": [
                "The patient has progressive memory loss and jerking movements, which could indicate dementia. However, the diagnosis of Alzheimer's Disease is not explicitly stated. The note does not mention other neurological diseases or serious/unstable illnesses that could interfere with the study.",
                [
                    1,
                    2
                ],
                "not enough information"
            ],
            "1": [
                "The patient's diagnosis and symptoms do not explicitly indicate a history of cancer with a high risk of recurrence.",
                [],
                "not excluded"
            ],
            "2": [
                "The patient has no mention of clinically significant multiple or severe drug allergies or hypersensitivity reactions.",
                [],
                "not excluded"
            ],
            "3": [
                "No clinically important laboratory test results or other abnormalities are mentioned that could be detrimental to the participant or compromise the study.",
                [],
                "not excluded"
            ],
            "4": [
                "No contraindications for MRI are mentioned.",
                [],
                "not excluded"
            ],
            "5": [
                "No mention of a centrally read MRI that does not meet study entry criteria.",
                [],
                "not excluded"
            ],
            "6": [
                "The patient has not had prior treatment with passive anti-amyloid immunotherapy or active immunization against A\u03b2.",
                [],
                "not excluded"
            ]
        }
    },
    "NCT06566170": {
        "inclusion": {
            "0": [
                "The patient is a 62-year-old man with progressive memory loss and cognitive deficits, which fits the description of early symptomatic Alzheimer's Disease (AD). However, the note does not specify if the patient is under care for mild cognitive impairment (MCI) or mild dementia stage of AD.",
                [
                    1,
                    2
                ],
                "not enough information"
            ],
            "1": [
                "The patient has a MMSE score of 21, which is above the required TICS score of \u226521.",
                [
                    6
                ],
                "included"
            ],
            "2": [
                "The patient note does not mention any amyloid beta (A\u03b2) pathology supported by biomarker results such as P-tau, amyloid PET, or CSF.",
                [],
                "not included"
            ],
            "3": [
                "The patient note does not mention the presence of a reliable study partner who is in frequent contact with the participant and available by telephone.",
                [],
                "not included"
            ],
            "4": [
                "The patient note does not mention if the patient has EHR data available for linkage or if the patient is willing to allow access to EHR data for the duration of the study.",
                [],
                "not enough information"
            ]
        },
        "exclusion": {
            "0": [
                "The criterion is applicable because the patient has a neurologic condition, but there is no mention of prior stroke or inability to perform basic activities of daily living (ADLs).",
                [],
                "not enough information"
            ],
            "1": [
                "The criterion is applicable because the patient has a serious neurological condition, but there is no mention of current or recent serious or unstable illness (other than AD) that could interfere with study completion.",
                [],
                "not enough information"
            ],
            "2": [
                "The criterion is not applicable because the patient is not mentioned to be enrolled or intending to enroll in another clinical trial.",
                [],
                "not applicable"
            ],
            "3": [
                "The criterion is applicable because the patient has a neurological condition, but there is no mention of contraindications to donanemab, MRI, or amyloid PET tracers.",
                [],
                "not enough information"
            ]
        }
    },
    "NCT06538116": {
        "inclusion": {
            "0": [
                "The patient has progressive memory loss, which fits the description of gradual and progressive decline in memory function. However, the note does not specify the duration of the decline. It is possible that the decline has been going on for more than 6 months, but it is not explicitly stated.",
                [
                    7
                ],
                "not enough information"
            ],
            "1": [
                "The patient's MMSE score is 21, which falls within the range of 13 to 24.",
                [],
                "included"
            ],
            "2": [
                "The note does not mention plasma P-tau levels or historical evidence of AD pathology.",
                [],
                "not enough information"
            ],
            "3": [
                "The note does not mention the presence of a reliable study partner who will provide written informed consent and be available for participation.",
                [],
                "not enough information"
            ],
            "4": [
                "The note does not provide information regarding the patient's gender or reproductive status.",
                [],
                "not enough information"
            ]
        },
        "exclusion": {
            "0": [
                "The criterion is not applicable because the patient note does not mention any individuals of childbearing potential.",
                [],
                "not applicable"
            ],
            "1": [
                "The patient note does not mention any other significant central nervous system or psychiatric diseases apart from the diagnosis of Alzheimer's disease. There is no direct evidence of other conditions affecting cognition or the ability to complete the study.",
                [],
                "not excluded"
            ],
            "2": [
                "The patient note does not mention any cardiovascular-related risk factors or history such as uncontrolled hypertension, heart failure, stroke, or liver-related abnormalities.",
                [],
                "not excluded"
            ],
            "3": [
                "The patient note does not mention the use of moderate or strong CYP3A4 inhibitors or inducers.",
                [],
                "not excluded"
            ],
            "4": [
                "The patient note does not mention participation in any other clinical trial within the last 30 days.",
                [],
                "not excluded"
            ],
            "5": [
                "The patient note does not mention any judgment by the investigator regarding the patient being actively suicidal.",
                [],
                "not excluded"
            ]
        }
    },
    "NCT06657768": {
        "inclusion": {
            "1": [
                "The patient is a 62-year-old man with progressive memory loss and cognitive deficits, which fits the symptomatic profile of early Alzheimer's Disease (AD). However, the note does not explicitly state a diagnosis of Alzheimer's Disease, only symptoms and findings that could be consistent with it. The patient note does not contain sufficient information to confirm the diagnosis, but the symptoms are suggestive. It is possible that a good patient note could miss such a diagnosis if it was not confirmed by a specialist, but this is less likely. Therefore, there is not enough information to definitively classify the patient's eligibility.",
                [],
                "not enough information"
            ],
            "2": [
                "The patient is over 55 years old, which meets the age requirement for early Alzheimer's Disease participants. The patient's age is explicitly mentioned in Sentence 1.",
                [
                    1
                ],
                "included"
            ],
            "3": [
                "The patient shows progressive memory loss, cognitive deficits, and EEG findings that are suggestive of Alzheimer's Disease, but there is no explicit confirmation of a diagnosis of Alzheimer's Disease. The patient's symptoms meet the symptomatic criteria, but without a confirmed diagnosis, there is not enough information.",
                [],
                "not enough information"
            ],
            "4": [
                "The patient's MMSE score is 21, which is below the typical threshold of 26 for early Alzheimer's Disease, but the note does not specify the exact MMSE criteria used in the study. Without this information, it is not possible to determine if this criterion is met.",
                [],
                "not enough information"
            ],
            "5": [
                "The patient is expected to provide informed consent and comply with the trial protocol without any practical issues, as stated in Sentence 7.",
                [
                    7
                ],
                "included"
            ],
            "6": [
                "The patient note does not provide information about the patient's general health status or other medical conditions that might exclude them from the study. It is not applicable to assume any exclusion based on this criterion without more information.",
                [],
                "not applicable"
            ]
        },
        "exclusion": {
            "1": [
                "The criterion is not applicable as the patient has progressive memory loss and jerking movements, indicating a neurological condition rather than being healthy. The patient note does not mention any healthy status.",
                [],
                "not applicable"
            ],
            "2": [
                "The criterion is not applicable as the patient has severe cognitive deficits and memory dysfunction, which are symptoms of Alzheimer's Disease, not early symptomatic Alzheimer's Disease.",
                [],
                "not applicable"
            ],
            "3": [
                "The patient has progressive memory loss and jerking movements, severe cognitive deficits, and memory dysfunction, which are indicative of Alzheimer's Disease rather than early symptomatic Alzheimer's Disease. The patient does not meet the inclusion criteria for early symptomatic AD.",
                [],
                "not applicable"
            ],
            "4": [
                "The patient has moderately advanced cerebral atrophy and diffuse vacuolar changes of the gray matter, which are indicative of Alzheimer's Disease rather than early symptomatic Alzheimer's Disease. The patient does not meet the inclusion criteria for early symptomatic AD.",
                [],
                "not applicable"
            ],
            "5": [
                "The patient has a MMSE score of 21, which is indicative of moderate cognitive impairment. The patient note does not provide information on whether the patient has early symptomatic Alzheimer's Disease.",
                [
                    "6"
                ],
                "not enough information"
            ],
            "6": [
                "The patient has progressive memory loss and jerking movements, which are not typical symptoms of healthy participants. The patient note does not provide information on whether the patient is healthy.",
                [],
                "not applicable"
            ]
        }
    },
    "NCT06809400": {
        "inclusion": {
            "0": [
                "The patient note does not provide information on the patient's body mass index (BMI). It is not possible to determine if the patient's BMI falls within the range of 18 to 34 kg/m\u00b2.",
                [],
                "not enough information"
            ],
            "1": [
                "The patient note does not provide information on the patient's body mass index (BMI). Venous access is not mentioned either.",
                [],
                "not enough information"
            ],
            "2": [
                "The patient note does not provide information on the patient's health status. The patient has progressive memory loss and jerking movements, which indicates an existing neurological condition.",
                [],
                "not included"
            ],
            "3": [
                "The patient note does not provide information on the patient's ethnic background or whether all four of the patient's biological grandparents are of exclusive Chinese descent and born in China.",
                [],
                "not enough information"
            ],
            "4": [
                "The patient note indicates that the patient has progressive memory loss and jerking movements, which are not symptoms of Parkinson's disease.",
                [],
                "not included"
            ],
            "5": [
                "The patient note does not provide information on the patient's Montreal Cognitive Assessment (MoCA) score. Additionally, the patient does not have a diagnosis of Parkinson's disease.",
                [],
                "not included"
            ]
        },
        "exclusion": {
            "0": [
                "The patient has progressive memory loss and jerking movements, indicating a neurological disease affecting the CNS. This is not Parkinson's disease, which is an exception in Part B cohorts. Therefore, the patient meets the exclusion criterion.",
                [
                    1,
                    2,
                    3,
                    4,
                    5
                ],
                "excluded"
            ],
            "1": [
                "The patient has severe cognitive deficits and memory dysfunction, and neuroimaging shows moderately advanced cerebral atrophy. These conditions are serious and unstable, potentially affecting the ability to complete the study and increasing risk. Therefore, the patient meets the exclusion criterion.",
                [
                    2,
                    4
                ],
                "excluded"
            ],
            "2": [
                "No information is provided about allergies to LY4006896, related compounds, or components of the formulation, or history of allergic reactions to any transferrin receptor antibodies. It is unlikely that a good patient note would miss such information, so it is reasonable to assume this criterion is not true for the patient.",
                [],
                "not excluded"
            ],
            "3": [
                "No information is provided about significant allergies to humanize monoclonal antibodies or clinically significant multiple or severe drug allergies. It is unlikely that a good patient note would miss such information, so it is reasonable to assume this criterion is not true for the patient.",
                [],
                "not excluded"
            ],
            "4": [
                "No information is provided about history or presence of uncontrolled asthma, significant autoimmune disease, hereditary angioedema, or known history of common variable immune deficiency. It is unlikely that a good patient note would miss such information, so it is reasonable to assume this criterion is not true for the patient.",
                [],
                "not excluded"
            ],
            "5": [
                "No information is provided about anemia. It is unlikely that a good patient note would miss such information, so it is reasonable to assume this criterion is not true for the patient.",
                [],
                "not excluded"
            ],
            "6": [
                "No information is provided about abnormal blood pressure or pulse rate, or a preexisting history of hypertension. It is unlikely that a good patient note would miss such information, so it is reasonable to assume this criterion is not true for the patient.",
                [],
                "not excluded"
            ],
            "7": [
                "No information is provided about abnormal blood pressure or pulse rate, or uncontrolled hypertension. It is unlikely that a good patient note would miss such information, so it is reasonable to assume this criterion is not true for the patient.",
                [],
                "not excluded"
            ]
        }
    },
    "NCT06220669": {
        "inclusion": {
            "0": [
                "The patient note does not mention any diagnosis or evidence of multiple sclerosis, nor does it mention relapsing-remitting multiple sclerosis. Therefore, the criterion is not applicable.",
                [],
                "not applicable"
            ],
            "1": [
                "The patient note does not mention any documented relapses or active GdE brain lesions on an MRI scan. Additionally, there is no evidence of relapsing-remitting multiple sclerosis, which is a requirement for this criterion. It is impossible for a good patient note to miss such important information if it were present.",
                [],
                "not applicable"
            ],
            "2": [
                "The patient note does not mention any documented relapses or active GdE brain lesions on an MRI scan. Additionally, there is no evidence of relapsing-remitting multiple sclerosis, which is a requirement for this criterion. It is impossible for a good patient note to miss such important information if it were present.",
                [],
                "not applicable"
            ],
            "3": [
                "The patient note does not provide an Expanded Disability Status Scale (EDSS) score. Without this information, it is impossible to determine if the patient meets the EDSS criterion.",
                [],
                "not enough information"
            ]
        },
        "exclusion": {
            "0": [
                "The patient note does not mention any diagnosis of primary progressive multiple sclerosis (MS) or nonactive secondary progressive MS, nor does it mention neuromyelitis optica spectrum disorder or a history of clinically significant central nervous system (CNS) disease.",
                [],
                "not applicable"
            ],
            "1": [
                "The patient note does not provide any evidence of a recent relapse with systemic corticosteroid administration within 30 days prior to randomization.",
                [],
                "not applicable"
            ],
            "2": [
                "The patient note does not mention any active GdE brain lesions or provide details about the MRI scan.",
                [],
                "not enough information"
            ],
            "3": [
                "The patient note does not mention any medications or treatments that the patient has received.",
                [],
                "not enough information"
            ],
            "4": [
                "The patient note does not mention any current or recent acute, active infection.",
                [],
                "not applicable"
            ],
            "5": [
                "The patient note does not mention any current serious or unstable illnesses.",
                [],
                "not applicable"
            ],
            "6": [
                "The patient note does not mention any other clinically important abnormality at screening or baseline.",
                [],
                "not enough information"
            ]
        }
    },
    "NCT06553872": {
        "inclusion": {
            "0": [
                "The patient note does not mention a diagnosis of mantle cell lymphoma (MCL). Therefore, the criterion is not applicable.",
                [],
                "not applicable"
            ],
            "1": [
                "The patient is 62 years old, which meets the age requirement of 18 years or older.",
                [],
                "included"
            ],
            "2": [
                "The note does not provide information on whether the patient can comprehend and sign written informed consent. However, it does mention the patient will comply with the trial protocol, which implies a level of understanding.",
                [],
                "included"
            ],
            "3": [
                "The patient note does not provide information on eligibility for CAR T-cell therapy.",
                [],
                "not enough information"
            ],
            "4": [
                "The patient note does not provide information on ECOG performance status.",
                [],
                "not enough information"
            ],
            "5": [
                "The patient note does not provide information on the washout periods prior to leukapheresis or prior treatment-related AEs.",
                [],
                "not enough information"
            ],
            "6": [
                "The patient note does not provide information on contraception or pregnancy status.",
                [],
                "not enough information"
            ],
            "7": [
                "The patient note does not provide information on laboratory parameters.",
                [],
                "not enough information"
            ]
        },
        "exclusion": {
            "0": [
                "The patient has not received pirtobrutinib for more than 2 months. The patient note does not mention any prior treatment with pirtobrutinib.",
                [],
                "not excluded"
            ],
            "1": [
                "The patient has not received any investigational study agent within 4 weeks prior to screening visit. The patient note does not mention any recent investigational study agent.",
                [],
                "not excluded"
            ],
            "2": [
                "The patient has not received CAR T-cell therapy before. The patient note does not mention any prior treatment with CAR T-cell therapy.",
                [],
                "not excluded"
            ],
            "3": [
                "There is no mention of clinically significant or uncontrolled cardiac disease in the patient note.",
                [],
                "not excluded"
            ],
            "4": [
                "There is no mention of uncontrolled or symptomatic arrhythmias in the patient note.",
                [],
                "not excluded"
            ],
            "5": [
                "There is no mention of active uncontrolled/untreated infection in the patient note.",
                [],
                "not excluded"
            ],
            "6": [
                "There is no mention of active immunologic or inflammatory/autoimmune disease affecting the CNS in the patient note.",
                [],
                "not excluded"
            ],
            "7": [
                "The patient does not have active CNS involvement of Mantle Cell Lymphoma. The patient note does not mention any CNS involvement.",
                [],
                "not excluded"
            ],
            "8": [
                "There is no mention of known positive Human immunodeficiency virus (HIV) status in the patient note.",
                [],
                "not excluded"
            ],
            "9": [
                "There is no mention of Hepatitis B virus (HBV) status in the patient note.",
                [],
                "not excluded"
            ],
            "10": [
                "There is no mention of Hepatitis C virus (HCV) status in the patient note.",
                [],
                "not excluded"
            ],
            "11": [
                "There is no mention of active cytomegalovirus (CMV) infection in the patient note.",
                [],
                "not excluded"
            ],
            "12": [
                "The patient does not require the concurrent use of chronic systemic steroids or immunosuppressant medications. The patient note does not mention any current use of these medications.",
                [],
                "not excluded"
            ],
            "13": [
                "There is no mention of known hypersensitivity or severe reaction to pirtobrutinib, similar compounds, or excipients in the patient note.",
                [],
                "not excluded"
            ],
            "14": [
                "The patient has not received prior anticancer therapy. The patient note does not mention any recent anticancer therapy.",
                [],
                "not excluded"
            ],
            "15": [
                "The patient is not pregnant or nursing. The patient note does not mention any pregnancy or breastfeeding.",
                [],
                "not excluded"
            ],
            "16": [
                "There is no mention of any condition that would interfere with full participation in the study.",
                [],
                "not excluded"
            ],
            "17": [
                "The patient is able to swallow and retain oral medication. The patient note does not mention any gastrointestinal issues.",
                [],
                "not excluded"
            ],
            "18": [
                "There is no mention of a major bleeding event or grade \u2265 3 arrhythmia on prior treatment with a BTK inhibitor.",
                [],
                "not excluded"
            ],
            "19": [
                "There is no mention of major surgery within 4 weeks prior to enrollment.",
                [],
                "not excluded"
            ],
            "20": [
                "There is no mention of a previously diagnosed hereditary bleeding disorder.",
                [],
                "not excluded"
            ],
            "21": [
                "The patient is not requiring therapeutic anticoagulation with warfarin or another vitamin K antagonist.",
                [],
                "not excluded"
            ],
            "22": [
                "There is no mention of active second malignancy.",
                [],
                "not excluded"
            ],
            "23": [
                "There is no mention of vaccination with live vaccine within 28 days prior to randomization.",
                [],
                "not excluded"
            ],
            "24": [
                "There is no mention of history of stroke or intracranial hemorrhage within 6 months of enrollment.",
                [],
                "not excluded"
            ],
            "25": [
                "There is no mention of history of allogeneic or autologous stem cell transplant within 60 days of enrollment.",
                [],
                "not excluded"
            ],
            "26": [
                "There is no mention of active uncontrolled autoimmune cytopenia.",
                [],
                "not excluded"
            ]
        }
    }
}